Reportee | Signature Date | Report period | Total Entries | Total AUM($) |
---|---|---|---|---|
CHIRON CAPITAL MANAGEMENT LLC | 02-12-2024 | 12-31-2023 | 117 | 114,947,482 |
Issuer | Class | Position | Value | Shares | Portfolio Percentage (%) | Previous Percentage (%) | Shares Delta | Shares Delta(%) | Date Reported |
---|---|---|---|---|---|---|---|---|---|
BRISTOL-MYERS SQUIBB CO | COM | 1 | $22,813,214 | 444,615 | 0.02 | 0.02 | -25,095 | -5.34 | 12-31-2023 |
SPDR SER TR | S&P BIOTECH | 2 | $12,553,192 | 140,589 | 0.01 | 0.01 | -8,117 | -5.46 | 12-31-2023 |
CVS HEALTH CORP | COM | 3 | $2,254,545 | 28,553 | 0.00 | 0.00 | 753 | 2.71 | 12-31-2023 |
ENTERPRISE PRODS PARTNERS L | COM | 4 | $1,965,856 | 74,606 | 0.00 | 0.00 | 3,701 | 5.22 | 12-31-2023 |